Literature DB >> 2734788

The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.

R M McClain1, A A Levin, R Posch, J C Downing.   

Abstract

The effect of phenobarbital on thyroid function and the metabolism and biliary excretion of thyroxine in rats was determined. Phenobarbital, administered for 2 weeks at a dose of 100 mg/kg/day, resulted in an increase in hepatic and thyroid gland weights, decreased circulating levels of T4, T3 and rT3, and increased TSH levels in male and female rats. After 3 months of treatment liver and thyroid weights were still increased; however, hormone values were not as markedly affected indicating that the rats had partially compensated for the effect on thyroid function. In thyroidectomized rats the plasma clearance of thyroxine was increased with phenobarbital. In bile duct cannulated phenobarbital-treated male rats the hepatic uptake at 4 hr was markedly increased. Bile flow was increased and the 4-hr cumulative biliary excretion of administered radioactivity was increased by 42%. Most of the increase in the excretion (76%) was accounted for by an increase in the excretion of thyroxine-glucuronide in phenobarbital-treated rats. Hepatic thyroxine-glucuronyltransferase activity in phenobarbital-treated rats expressed as picomoles per milligram of protein was increased by 40%; enzyme activity per gram of liver was increased by about twofold which, coupled with increased hepatic weight, resulted in about a threefold increase in total hepatic thyroxine-glucuronyltransferase activity in phenobarbital-treated rats as compared to that of controls. Qualitatively similar effects on metabolism, excretion, and enzyme induction were noted in female rats; however, the magnitude of increase was less than that observed in male rats. It is concluded that the effect of phenobarbital on thyroid function in rats is primarily a result of its effects on the hepatic disposition of thyroid hormone. The induction of thyroxine-glucuronyltransferase appears to play an important role in the increased metabolism and excretion of thyroxine in phenobarbital-treated rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734788     DOI: 10.1016/0041-008x(89)90004-5

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.

Authors:  L A Martin; D T Wilson; K R Reuhl; M A Gallo; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2011-12-20       Impact factor: 3.922

3.  Role of UDP-glucuronosyltransferase (UGT) 2B2 in metabolism of triiodothyronine: effect of microsomal enzyme inducers in Sprague Dawley and UGT2B2-deficient Fischer 344 rats.

Authors:  Terrilyn A Richardson; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2010-04-26       Impact factor: 4.849

4.  Short-term influence of prednisone and phenobarbital on thyroid function in euthyroid dogs.

Authors:  S Daminet; M Paradis; K R Refsal; C Price
Journal:  Can Vet J       Date:  1999-06       Impact factor: 1.008

5.  Disruption of thyroid hormone homeostasis in Ugt1a-deficient Gunn rats by microsomal enzyme inducers is not due to enhanced thyroxine glucuronidation.

Authors:  Terrilyn A Richardson; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-07-22       Impact factor: 4.219

6.  Effects of thyroid status and thyrostatic drugs on hepatic glucuronidation of lodothyronines and other substrates in rats : Induction of phenol UDP-glucuronyltransferase by methimazole.

Authors:  T J Visser; E Kaptein; A Gijzel; W W de Herder; M L Cannon; F Bonthuis; W J de Greef
Journal:  Endocrine       Date:  1996-02       Impact factor: 3.633

Review 7.  A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer.

Authors:  John R Foster; Helen Tinwell; Stephanie Melching-Kollmuss
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

8.  Assessment of the labelling index of cohorts of the pancreatic islet cell population in phenobarbitone-treated male rats using a double immunohistochemical technique for 5-bromo-2'-deoxyuridine and pancreatic hormones.

Authors:  H B Jones; S J Harbottle; A L Bowdler
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in the rat using bromodeoxyuridine immunocytochemistry.

Authors:  H B Jones; N A Clarke
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

10.  Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats.

Authors:  Katie B Paul; Joan M Hedge; Michael J DeVito; Kevin M Crofton
Journal:  Toxicol Sci       Date:  2009-11-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.